Real-World Analysis of Clinical Characteristics, Treatment Patterns, and Patient-Reported Outcomes of Insufficient Responders and Responders to Prescribed Acute Migraine Treatment in China-Reference-Cited by-同舟云学术

Real-World Analysis of Clinical Characteristics, Treatment Patterns, and Patient-Reported Outcomes of Insufficient Responders and Responders to Prescribed Acute Migraine Treatment in China

Published:2023-03-22 Issue:3 Volume:12 Page:751-769
ISSN:2193-8237
Container-title:Pain and Therapy
language:en
Short-container-title:Pain Ther

Author:

Zhang Lei,Novick Diego,Zhong Shiying^ORCID,Li Jinnan^ORCID,Walker Chloe,Harrison Lewis,Jackson James^ORCID,Barlow Sophie,Cotton Sarah

Funder

Eli Lilly and Company Indianapolis

Publisher

Springer Science and Business Media LLC

Subject

Anesthesiology and Pain Medicine,Neurology (clinical)

Link

https://link.springer.com/content/pdf/10.1007/s40122-023-00494-1.pdf

Reference43 articles.

1. Eigenbrodt AK, Ashina H, Khan S, et al. Diagnosis and management of migraine in ten steps. Nat Rev Neurol. 2021;17(8):501–14.

2. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–59.

3. Yao C, Wang Y, Wang L, et al. Burden of headache disorders in China, 1990–2017: findings from the Global Burden of Disease Study 2017. J Headache Pain. 2019;20(1):102.

4. Chinese Medical Association Group. Guide to the prevention and treatment of migraine in China [Chinese]. Chin J Pain Med. 2016;22:721–7.

5. Yu S, Zhang Y, Yao Y, Cao H. Migraine treatment and healthcare costs: retrospective analysis of the China Health Insurance Research Association (CHIRA) database. J Headache Pain. 2020;21(1):53.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in adults from China: a subgroup analysis of a double-blind, randomized, placebo-controlled, phase 3 clinical trial;The Journal of Headache and Pain;2024-04-16